IDYA
IDEAYA Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.99
+2.09%Next report
Analyst consensus
- Next report date
- Feb 16, 2027
- EPS estimate
- -$1.13
- Revenue estimate
- $18.7M
Latest reported
- Last report date
- Nov 3, 2026
- EPS actual
- -$1.22
- EPS estimate
- -$1.18
- Revenue actual
- $10.2M
- Revenue estimate
- $7.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -3.4%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $53
- PT range
- $42 – $60
- Analysts
- 6
6 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 3, 2026 | -$1.18 | -$1.22 | Miss -3.39% | $10.2M |
| Aug 4, 2026 | -$1.06 | -$1.22 | Miss -15.09% | $8.9M |
| May 5, 2026 | -$1.07 | -$1.11 | Miss -3.74% | $6.6M |
| Feb 17, 2026 | -$1.03 | -$0.94 | Beat 8.74% | $10.9M |
| Feb 13, 2025 | -$0.67 | -$1.49 | Miss -122.39% | $7.0M |
| Feb 20, 2024 | -$0.49 | -$0.52 | Miss -6.12% | $3.9M |
| Aug 10, 2023 | -$0.53 | -$0.50 | Beat 5.66% | $3.5M |
| Mar 7, 2023 | -$0.57 | -$0.50 | Beat 12.28% | $4.0M |
| Aug 15, 2022 | -$0.57 | -$0.57 | In line | $5.9M |
| Mar 15, 2022 | -$0.31 | -$0.47 | Miss -51.61% | $3.0M |
| Nov 15, 2021 | -$0.29 | -$0.31 | Miss -6.90% | $9.0M |
| Aug 10, 2021 | -$0.07 | -$0.33 | Miss -371.43% | $8.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 16, 2027